A lactate‐responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple‐negative breast cancer

Author:

Feng Kaixiang1,Shao Youcheng2,Li Jun1,Guan Xiaoqing2,Liu Qin2ORCID,Hu Meishun1,Chu Mengfei3,Li Hui2,Chen Fangfang1,Yi Zongbi4ORCID,Zhang Jingwei1ORCID

Affiliation:

1. Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors Hubei Cancer Clinical Study Center Wuhan China

2. Department of Pathology and Pathophysiology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, TaiKang Medical School (School of Basic Medical Sciences) Wuhan University Wuhan China

3. Department of Human Anatomy, TaiKang Medical School (School of Basic Medical Sciences) Wuhan University Wuhan China

4. Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors Hubei Cancer Clinical Study Center Wuhan China

Abstract

AbstractBackgroundIncreased glycolytic activity and lactate production are characteristic features of triple‐negative breast cancer (TNBC). The aim of this study was to determine whether a subset of lactate‐responsive genes (LRGs) could be used to classify TNBC subtypes and predict patient outcomes.MethodsLactate levels were initially measured in different breast cancer (BC) cell types. Subsequently, MDA‐MB‐231 cells treated with 2‐Deoxy‐d‐glucose or l‐lactate were subjected to RNA sequencing (RNA‐seq). The gene set variation analysis algorithm was utilized to calculate the lactate‐responsive score, conduct a differential analysis, and establish an association with the extent of immune infiltration. Consensus clustering was then employed to classify TNBC patients. Tumor immune dysfunction and exclusion, cibersort, single‐sample gene set enrichment analysis, and EPIC, were used to compare the tumor‐infiltrating immune cells between TNBC subtypes and predict the response to immunotherapy. Furthermore, a prognostic model was developed by combining 98 machine learning algorithms, to assess the predictive significance of the LRG signature. The predictive value of immune infiltration and the immunotherapy response was also assessed. Finally, the association between lactate and various anticancer drugs was examined based on expression profile similarity principles.ResultsWe found that the lactate levels of TNBC cells were significantly higher than those of other BC cell lines. Through RNA‐seq, we identified 14 differentially expressed LRGs in TNBC cells under varying lactate levels. Notably, this LRG signature was associated with interleukin‐17 signaling pathway dysregulation, suggesting a link between lactate metabolism and immune impairment. Furthermore, the LRG signature was used to categorize TNBC into two distinct subtypes, whereby Subtype A was characterized by immunosuppression, whereas Subtype B was characterized by immune activation.ConclusionWe identified an LRG signature in TNBC, which could be used to predict the prognosis of patients with TNBC and gauge their response to immunotherapy. Our findings may help guide the precision treatment of patients with TNBC.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3